Beam Therapeutics Inc

23 de set. de 2026, 20:07 UTC

Beam Therapeutics Inc shares fell sharply, potentially influenced by declines in the Direxion Daily S&P Biotech Bull 3X ETF amid broader market weakness.

22 de set. de 2026, 19:15 UTC

Beam Therapeutics Inc has achieved four consecutive sessions of gains, reaching a peak return earlier today, though it remains below its 20-day moving average.

21 de set. de 2026, 23:06 UTC

Beam Therapeutics Inc saw a slight gain in after-market trading, fluctuating positively but remaining below its 20-day moving average and near the lower end of its one-month range.

18 de set. de 2026, 19:56 UTC

Beam Therapeutics Inc is trading higher amid modest gains, despite remaining significantly below its 20-day moving average following unchanged U.S. industrial production data.

17 de set. de 2026, 23:01 UTC

Beam Therapeutics Inc is advancing in after-market trading, rebounding from earlier lows and maintaining upward momentum alongside Editas Medicine Inc.

16 de set. de 2026, 23:06 UTC

Beam Therapeutics Inc is trading roughly flat in after-market hours, impacted by broader biotechnology sector weakness, while CRISPR Therapeutics AG is slightly higher.

15 de set. de 2026, 23:01 UTC

Beam Therapeutics Inc is trading higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain this movement.

14 de set. de 2026, 20:08 UTC

Beam Therapeutics Inc is advancing during Monday's session, recovering from earlier losses as discussions around Phase 2 data on alpha-1 antitrypsin deficiency continue.

11 de set. de 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, likely influenced by a rise in CRISPR Therapeutics following a narrower-than-expected U.S. budget deficit.

10 de set. de 2026, 23:11 UTC

Beam Therapeutics Inc shares declined in after-market trading, marking the fourth consecutive session of losses and closing significantly below their 20-day moving average.

9 de set. de 2026, 23:06 UTC

Beam Therapeutics shares are trading higher in after-market hours following a presentation at Citigroup's Biopharma Summit, highlighting advancements in its pipeline.

8 de set. de 2026, 20:03 UTC

Beam Therapeutics shares are lower despite presenting promising clinical data for BEAM-302 therapy at the European Respiratory Society Congress, amid regulatory concerns.

4 de set. de 2026, 23:00 UTC

Beam Therapeutics Inc shares are trading higher in after-market hours, continuing a steady increase since Friday's close amid mixed economic signals.

1 de set. de 2026, 19:36 UTC

Beam Therapeutics appointed Eric Foster as chief commercial officer. Shares are trading lower despite the leadership change amid preparations for a 2027 product launch.

31 de ago. de 2026, 19:16 UTC

Beam Therapeutics Inc. shares are trading roughly flat, with no specific news identified. The stock remains above its 20-day moving average.

28 de ago. de 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, advancing since Friday's close and positioned above its 20-day moving average.

27 de ago. de 2026, 23:02 UTC

Beam Therapeutics Inc. shares are roughly flat in after-market hours with no specific news identified. The stock remains above its 20-day moving average.

26 de ago. de 2026, 23:51 UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

25 de ago. de 2026, 20:07 UTC

HC Wainwright reiterated its Buy rating on Beam Therapeutics, maintaining a $80 price target. Shares are gaining amid positive sentiment and elevated call activity.

24 de ago. de 2026, 20:06 UTC

Beam Therapeutics Inc shares are lower today amid rising oil prices and geopolitical tensions, with no specific news identified to explain the decline.

21 de ago. de 2026, 23:31 UTC

Beam Therapeutics Inc. shares gained in after-market trading, reflecting broader market recovery as traders engaged in bargain hunting following a recent downturn.

20 de ago. de 2026, 22:16 UTC

Beam Therapeutics Inc. shares advanced in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

19 de ago. de 2026, 23:06 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

18 de ago. de 2026, 19:16 UTC

Shares of Beam Therapeutics are lower today, having declined since Monday amid broader small-cap losses and rising U.S. Treasury yields.

14 de ago. de 2026, 19:36 UTC

Beam Therapeutics is trading higher during Friday's session, recovering from an earlier dip. No specific news has been identified to explain the price action.

13 de ago. de 2026, 23:01 UTC

Beam Therapeutics Inc. shares are higher in after-market trading, reflecting notable upward momentum since Thursday's close, despite no specific news identified.

12 de ago. de 2026, 20:06 UTC

Beam Therapeutics Inc. shares are lower today, continuing a trend of declines since Tuesday's close amid broader market uncertainties and lower U.S. Treasury yields.

11 de ago. de 2026, 23:06 UTC

Beam Therapeutics shares are higher in after-market trading, following a session peak. No specific news was identified to explain the price movement.

5 de ago. de 2026, 19:52 UTC

Beam Therapeutics Inc is trading lower as broader market sentiment weakens. The decline follows disappointing ADP employment data, which missed expectations significantly.

4 de ago. de 2026, 23:06 UTC

Beam Therapeutics Inc. shares are lower in after-market hours, following a session low shortly after the open, despite three consecutive higher daily closes.